ArticleScientific reports2025
Early diagnosis of nasopharyngeal carcinoma based on machine learning modelling and blood plasma metallomics analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current diagnosis of nasopharyngeal carcinoma (NPC) mainly relies on detection of plasma Epstein-Barr virus DNA or nasal endoscopy. However, trace metals or other elements may have critical roles in the pathophysiology of NPC. In this pilot study, blood plasma samples from 93 NPC patients and 30 healthy control were prepared by alkali dilution method, and metal contents were analysed quantitatively by inductively coupled plasma-mass spectrometry. We then built six machine learning (ML) algorithms based on the element concentrations in blood plasma and evaluated the predictive performance by the area under the receiver operating characteristic curve (AUC). SHapley Additive exPlanations was employed to interpret the prediction results and explain the contribution of each variable to the model. Compared to the healthy control group, patients with NPC were characterised by increased tin (p < 0.01) and reduced in nickel and iron (p < 0.05), phosphorus (p < 0.01), magnesium, manganese, cobalt, zinc, strontium, molybdenum, antimony, barium, thallium and lead (p < 0.001) concentrations in the plasma. Among the ML models, the bagging model demonstrated the most promising performance in discriminating NPC patients with AUC of 0.999 in testing sets. We further recruited 15 patients with esophageal squamous cell carcinoma (ESCC), 15 non-cancer patients, and used them as blind testing samples. The model can successfully identify NPC patients from those samples with AUC and specificity of 0.857 and 0.800. In summary, the present pilot study highlights the use of metallomics analysis combined with machine learning in NPC identification, especially in early-stage cancer prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.